Literature DB >> 7041322

Presence of fibronectin in pneumoconiotic lesions.

J C Wagner, J Burns, D E Munday, J O McGee.   

Abstract

During the last 10 years our investigations have confirmed that collagen is not the major protein material in the lesions of progressive massive fibrosis of coal workers. In previous studies it was demonstrated that a substance similar in composition to fibrin was an important component in these masses. We report immunohistochemical studies on the lungs of seven coalworkers which show that the complex extracellular material in six of the lesions of massive fibrosis contains fibronectin. Preliminary observations indicate that fibronectin is also present in the lesions of silicosis and asbestosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7041322      PMCID: PMC459245          DOI: 10.1136/thx.37.1.54

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  4 in total

1.  The composition of massive lesions in coal miners.

Authors:  J C Wagner; F S Wusteman; J H Edwards; R J Hill
Journal:  Thorax       Date:  1975-08       Impact factor: 9.139

2.  Immunoperoxidase localisation of fibronectin in glomeruli of formalin fixed paraffin processed renal tissue.

Authors:  J Burns; A J Dixon; J C Woods
Journal:  Histochemistry       Date:  1980

3.  Distribution of fibronectin in normal and diseased human kidneys.

Authors:  A J Dixon; J Burns; M S Dunnill; J O McGee
Journal:  J Clin Pathol       Date:  1980-11       Impact factor: 3.411

4.  Distribution of a major connective tissue protein, fibronectin, in normal human tissues.

Authors:  S Stenman; A Vaheri
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

  4 in total
  2 in total

Review 1.  Pathogenesis of silicosis: current concepts and hypotheses.

Authors:  G S Davis
Journal:  Lung       Date:  1986       Impact factor: 2.584

Review 2.  Prevalence and pathogenesis of pneumoconiosis in coal workers.

Authors:  A G Heppleston
Journal:  Environ Health Perspect       Date:  1988-06       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.